Vera Therapeutics, Inc. (VERA)
34.19
-0.41
(-1.18%)
USD |
NASDAQ |
Aug 28, 16:00
34.22
+0.03
(+0.09%)
After-Hours: 20:00
Vera Therapeutics Total Assets (Quarterly) : 532.98M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 532.98M |
| March 31, 2026 | 621.74M |
| December 31, 2025 | 735.30M |
| September 30, 2025 | 517.50M |
| June 30, 2025 | 578.53M |
| March 31, 2025 | 610.17M |
| December 31, 2024 | 656.47M |
| September 30, 2024 | 368.56M |
| June 30, 2024 | 397.29M |
| March 31, 2024 | 419.36M |
| December 31, 2023 | 175.55M |
| September 30, 2023 | 175.62M |
| Date | Value |
|---|---|
| June 30, 2023 | 195.18M |
| March 31, 2023 | 209.60M |
| December 31, 2022 | 131.44M |
| September 30, 2022 | 131.37M |
| June 30, 2022 | 148.78M |
| March 31, 2022 | 164.97M |
| December 31, 2021 | 83.75M |
| September 30, 2021 | 91.17M |
| June 30, 2021 | 97.65M |
| March 31, 2021 | 51.82M |
| December 31, 2020 | 54.55M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 125.23M |
| Shareholders Equity (Quarterly) | 407.76M |
| Debt to Equity Ratio | 0.1845 |
| Current Ratio | 10.65 |
| Net Debt Paydown Yield | -0.13% |